Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 669

1.

Current age and race adjusted prostate specific antigen threshold values delay diagnosis of high grade prostate cancer.

Reed A, Ankerst DP, Pollock BH, Thompson IM, Parekh DJ.

J Urol. 2007 Nov;178(5):1929-32; discussion 1932. Epub 2007 Sep 17.

PMID:
17868724
2.

Racial variations in the performance of prostate specific antigen and prostate specific antigen density in the era of extended prostate biopsy schemes.

Elliott CS, Shinghal R, Presti JC Jr.

J Urol. 2008 Oct;180(4):1318-23; discussion 1323-4. doi: 10.1016/j.juro.2008.06.031. Epub 2008 Aug 15.

PMID:
18707710
3.

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Thompson IM, Ankerst DP, Chi C, Goodman PJ, Tangen CM, Lucia MS, Feng Z, Parnes HL, Coltman CA Jr.

J Natl Cancer Inst. 2006 Apr 19;98(8):529-34.

4.

Prostate specific antigen levels in young adulthood predict prostate cancer risk: results from a cohort of Black and White Americans.

Whittemore AS, Cirillo PM, Feldman D, Cohn BA.

J Urol. 2005 Sep;174(3):872-6; discussion 876.

PMID:
16093978
5.

Should the age specific prostate specific antigen cutoff for prostate biopsy be higher for black than for white men older than 50 years?

Powell IJ, Banerjee M, Novallo M, Sakr W, Grignon D, Wood DP, Pontes JE.

J Urol. 2000 Jan;163(1):146-8; discussion 148-9.

PMID:
10604333
6.

Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men.

Smith DS, Carvalhal GF, Mager DE, Bullock AD, Catalona WJ.

J Urol. 1998 Nov;160(5):1734-8.

PMID:
9783942
7.

Screening for prostate cancer in high risk populations.

Catalona WJ, Antenor JA, Roehl KA, Moul JW.

J Urol. 2002 Nov;168(5):1980-3; discussion 1983-4.

PMID:
12394689
8.

Is race a positive predictor of cancer on repeat prostate biopsy?

Yanke BV, Salzhauer EW, Colon I.

J Urol. 2006 Sep;176(3):1114-7.

PMID:
16890704
9.

Rates of biochemical remission remain higher in black men compared to white men after radical prostatectomy despite similar trends in prostate specific antigen induced stage migration.

Wood HM, Reuther AM, Gilligan TD, Kupelian PA, Modlin CS Jr, Klein EA.

J Urol. 2007 Oct;178(4 Pt 1):1271-6. Epub 2007 Aug 14.

PMID:
17698101
11.

Initial prostate specific antigen 1.5 ng/ml or greater in men 50 years old or younger predicts higher prostate cancer risk.

Tang P, Sun L, Uhlman MA, Robertson CN, Polascik TJ, Albala DM, Donatucci CF, Moul JW.

J Urol. 2010 Mar;183(3):946-50. doi: 10.1016/j.juro.2009.11.021. Epub 2010 Jan 18.

PMID:
20083275
12.

Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial.

Thompson IM, Pauler Ankerst D, Chi C, Goodman PJ, Tangen CM, Lippman SM, Lucia MS, Parnes HL, Coltman CA Jr.

J Clin Oncol. 2007 Jul 20;25(21):3076-81.

13.

Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men.

Eastham JA, Carver B, Katz J, Kattan MW.

Prostate. 2002 Mar 1;50(4):236-40.

PMID:
11870801
15.

Risk of prostate cancer for young men with a prostate specific antigen less than their age specific median.

Loeb S, Nadler RB, Roehl KA, Antenor JA, Catalona WJ.

J Urol. 2007 May;177(5):1745-8.

PMID:
17437803
16.

Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

Ankerst DP, Groskopf J, Day JR, Blase A, Rittenhouse H, Pollock BH, Tangen C, Parekh D, Leach RJ, Thompson I.

J Urol. 2008 Oct;180(4):1303-8; discussion 1308. doi: 10.1016/j.juro.2008.06.038. Epub 2008 Aug 15. Erratum in: J Urol. 2009 Mar;181(3):1507.

PMID:
18707724
18.

Prostate-specific antigen as predictor of prostate cancer in black men and white men.

Whittemore AS, Lele C, Friedman GD, Stamey T, Vogelman JH, Orentreich N.

J Natl Cancer Inst. 1995 Mar 1;87(5):354-60.

PMID:
7531773
19.

Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada.

Whittemore AS, Wu AH, Kolonel LN, John EM, Gallagher RP, Howe GR, West DW, Teh CZ, Stamey T.

Am J Epidemiol. 1995 Apr 15;141(8):732-40.

PMID:
7535977
20.

Prostate cancer risk assessment program: a 10-year update of cancer detection.

Giri VN, Beebe-Dimmer J, Buyyounouski M, Konski A, Feigenberg SJ, Uzzo RG, Hanks G, Godwin AK, Chen DY, Gordon R, Cescon T, Raysor S, Watkins-Bruner D.

J Urol. 2007 Nov;178(5):1920-4; discussion 1924. Epub 2007 Sep 17.

PMID:
17868726
Items per page

Supplemental Content

Write to the Help Desk